Cardiac Dimensions Raises $35M to Advance Carillon System for Treating Mitral Valve Regurgitation

Cardiac Dimensions raised $35 million to support testing and marketing of its Carillon Mitral Contour System, a minimally invasive device for treating mitral valve regurgitation linked to heart failure. The funds will expand European sales and finance a U.S.-based clinical study involving major medical centers.

UUniversity of Washington